Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy
Top Cited Papers
- 17 February 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (5), 2576-2607
- https://doi.org/10.1021/acs.jmedchem.0c01846
Abstract
Heterobifunctional compounds that direct the ubiquitination of intracellular proteins in a targeted manner via co-opted ubiquitin ligases have enormous potential to transform the field of medicinal chemistry. These chimeric molecules, often termed proteolysis-targeting chimeras (PROTACs) in the chemical literature, enable the controlled degradation of specific proteins via their direction to the cellular proteasome. In this report, we describe the second phase of our research focused on exploring antibody–drug conjugates (ADCs), which incorporate BRD4-targeting chimeric degrader entities. We employ a new BRD4-binding fragment in the construction of the chimeric ADC payloads that is significantly more potent than the corresponding entity utilized in our initial studies. The resulting BRD4-degrader antibody conjugates exhibit potent and antigen-dependent BRD4 degradation and antiproliferation activities in cell-based experiments. Multiple ADCs bearing chimeric BRD4-degrader payloads also exhibit strong, antigen-dependent antitumor efficacy in mouse xenograft assessments that employ several different tumor models.Keywords
This publication has 83 references indexed in Scilit:
- Targeting bromodomains: epigenetic readers of lysine acetylationNature Reviews Drug Discovery, 2014
- Antibody–Drug Conjugates: An Emerging Concept in Cancer TherapyAngewandte Chemie, 2014
- A Self-Immolative Spacer That Enables Tunable Controlled Release of Phenols under Neutral ConditionsThe Journal of Organic Chemistry, 2012
- Selective inhibition of BET bromodomainsNature, 2010
- Covalent Inhibition of Bacterial Quorum SensingJournal of the American Chemical Society, 2009
- Application of human CFU-Mk assay to predict potential thrombocytotoxicity of drugsToxicology in Vitro, 2009
- Application of in Situ Silylation for Improved, Convenient Preparation of Fluorenylmethoxycarbonyl (Fmoc)-Protected Phosphinate Amino AcidsThe Journal of Organic Chemistry, 2007
- Immobilized liposome and biomembrane partitioning chromatography of drugs for prediction of drug transportInternational Journal of Pharmaceutics, 1998
- Efficient synthesis of γ-methyl-capped guanosine 5′-triphosphate as a 5′-terminal unique structure of U6 RNA via a new triphosphate bond formation involving activation of methyl phosphorimidazolidate using ZnCl2 as a catalyst in DMF under anhydrous conditionsTetrahedron Letters, 1997
- THE COVALENT STRUCTURE OF AN ENTIRE γG IMMUNOGLOBULIN MOLECULEProceedings of the National Academy of Sciences of the United States of America, 1969